Browsing: cancer
koto_fejaAstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said on Friday that the European Medicines Agency (EMA) endorsed ENHERTU for the treatment of…
Dave HarveyBusiness and Environment Correspondent, BBC WestBBCResearch scientists at the Bristol start-up are trying to transform the production of nuclear…
hapabapa A sBLA submitted by Bristol Myers Squibb (NYSE:BMY) for a combination of Opdivo (nivolumab) + Yervoy (ipilimumab) for microsatellite…
kyolshinShares of Arcus Biosciences (NYSE:RCUS) hit a new 52-week low on Tuesday after the biotech said that Gilead Sciences’ (NASDAQ:GILD)…
Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) announced Tuesday that the European Commission approved its anti-cancer agent Welireg (belzutifan) as a…
Rebeca Moen Feb 05, 2025 02:45BioTuring’s AI model offers detailed cellular visualizations of cancer, enhancing understanding of tumor dynamics and…
Mario TamaAn attorney representing the U.S. Department of Health & Human Services (HHS) said on Friday that the agency will…
Md Saiful Islam KhanPfizer (NYSE:PFE) announced Saturday that its colorectal cancer therapy Braftovi, as part of a combination regimen, reduced…
hapabapa/iStock Editorial via Getty ImagesBristol Myers Squibb (NYSE:BMY) announced Saturday that its checkpoint inhibitors Opdivo and Yervoy, when combined, reduced…
Mario Tama/Getty Images NewsThe U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) KRASG12C inhibitor Lumakras as part of…